Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling

American Journal of Transplantation

Volumn 14, Issue 5, 2014, Pages 1164-1172

  Kurian, S M ^a,j   Williams, A N ^a,j   Gelbart, T ^a,j   Campbell, D ^a,j   Mondala, T S ^a,j   Head, S R ^a,j   Horvath, S ^b,j   Gaber, L ^c,j   Thompson, R ^a   Whisenant, T ^a   Lin, W ^b,j   Langfelder, P ^b,j   Robison, E H ^a,j   Schaffer, R L ^d,j   Fisher, J S ^d,j   Friedewald, J ^e   Flechner, S M ^f,j   Chan, L K ^g,j   Wiseman, A C ^g,j   Shidban, H ^h,j   Mendez, R ^h,j   Heilman, R ^i,j   Abecassis, M M ^e   Marsh, C L ^d,j   Salomon, D R ^a,d,j   more..

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EAST TEXAS MEDICAL CENTER   (United States)

^d SCRIPPS CLINIC   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF COLORADO HOSPITAL   (United States)

^h ST VINCENT MEDICAL CENTER   (United States)

ⁱ MAYO CLINIC   (United States)

^j Transplant Genomics Collaborative Group (TGCG)   (United States)

more..

Author keywords

Acute dysfunction with no rejection; acute kidney rejection; gene expression profiling; microarrays; molecular classifiers

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GOLD STANDARD; GRAFT SURVIVAL; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY GRAFT REJECTION; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL GRAFT DYSFUNCTION; SENSITIVITY AND SPECIFICITY; BLOOD; CLASSIFICATION; COMPLICATION; FOLLOW UP; GENETICS; GRAFT REJECTION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LABORATORY DIAGNOSIS; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

BIOLOGICAL MARKER;

ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; FALSE NEGATIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GRAFT REJECTION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84899012442     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12671     Document Type: Article

References (39)

1. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B., Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383.
2. Rush D, Somorjai R, Deslauriers R, Shaw A, Jeffery J, Nickerson P., Subclinical rejection-A potential surrogate marker for chronic rejection-May be diagnosed by protocol biopsy or urine spectroscopy. Ann Transplant 2000; 5: 44-49.
3. Moreso F, Ibernon M, Goma M, et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6: 747-752.
4. Nankivell BJ., Subclinical renal allograft rejection and protocol biopsies: Quo vadis ? Nat Clin Pract Nephrol 2008; 4: 134-135.
5. US Department of Health and Human Services. OPTN/SRTR Annual Report. Available at: http://www.ustransplant.org/annual-reports/current/509a-ki.htm. Accessed February 12, 2013.
6. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR., The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333.
7. Chapman JR., Longitudinal analysis of chronic allograft nephropathy: Clinicopathologic correlations. Kidney Int Suppl 2005; S108-S112.
8. Schwarz A, Mengel M, Gwinner W, et al. Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int 2005; 67: 341-348.
9. Lerut E, Kuypers DR, Verbeken E, et al. Acute rejection in non-compliant renal allograft recipients: A distinct morphology. Clin Transplant 2007; 21: 344-351.
10. Morrissey PE, Reinert S, Yango A, Gautam A, Monaco A, Gohh R., Factors contributing to acute rejection in renal transplantation: The role of noncompliance. Transplant Proc 2005; 37: 2044-2047.
11. Mengel M, Gwinner W, Schwarz A, et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007; 7: 356-365.
12. Yilmaz S, Isik I, Afrouzian M, et al. Evaluating the accuracy of functional biomarkers for detecting histological changes in chronic allograft nephropathy. Transpl Int 2007; 20: 608-615.
13. Shapiro R, Randhawa P, Jordan ML, et al. An analysis of early renal transplant protocol biopsies-The high incidence of subclinical tubulitis. Am J Transplant 2001; 1: 47-50.
14. Hymes LC, Warshaw BL, Hennigar RA, Amaral SG, Greenbaum LA., Prevalence of clinical rejection after surveillance biopsies in pediatric renal transplants: Does early subclinical rejection predispose to subsequent rejection episodes ? Pediatr Transplant 2009; 13: 823-826.
15. Moreso F, Carrera M, Goma M, et al. Early subclinical rejection as a risk factor for late chronic humoral rejection. Transplantation 2012; 93: 41-46.
16. Flechner SM, Kurian SM, Head SR, et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004; 4: 1475-1489.
17. Gibbs PJ, Tan LC, Sadek SA, Howell WM., Quantitative detection of changes in cytokine gene expression in peripheral blood mononuclear cells correlates with and precedes acute rejection in renal transplant recipients. Transpl Immunol 2005; 14: 99-108.
18. Li L, Khatri P, Sigdel TK, et al. A peripheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant 2012; 12: 2710-2718.
19. Sabek O, Dorak MT, Kotb M, Gaber AO, Gaber L., Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation. Transplantation 2002; 74: 701-707.
20. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125-138.
21. Simon T, Opelz G, Wiesel M, Ott RC, Susal C., Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 2003; 3: 1121-1127.
22. Vasconcellos LM, Schachter AD, Zheng XX, et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998; 66: 562-566.
23. Lee JW, Devanarayan V, Barrett YC, et al. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm Res 2006; 23: 312-328.
24. Chau CH, Rixe O, McLeod H, Figg WD., Validation of analytic methods for biomarkers used in drug development. Clin Cancer Res 2008; 14: 5967-5976.
25. Dabney AR., Classification of microarrays to nearest centroids. Bioinformatics 2005; 21: 4148-4154.
26. Shen R, Ghosh D, Chinnaiyan A, Meng Z., Eigengene-based linear discriminant model for tumor classification using gene expression microarray data. Bioinformatics 2006; 22: 2635-2642.
27. Zhu Y, Shen X, Pan W., Network-based support vector machine for classification of microarray samples. BMC Bioinformatics 2009; 10 (Suppl 1): S21.
28. Miao YM, Cenzer IS, Kirby KA, Boscardin JW., Estimating Harrell's optimism on predictive indices using bootstrap samples. SAS Global Forum 2013, San Francisco Available at: http://support.sas.com/resources/papers/ proceedings13/504-2013.pdf. Accessed October 28, 2013.
29. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753-760.
30. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF., Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312-2323.
31. Wiebe C, Gibson IW, Blydt-Hansen TD, et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 2012; 12: 1157-1167.
32. McCall MN, Bolstad BM, Irizarry RA., Frozen robust multiarray analysis (fRMA). Biostatistics 2010; 11: 242-253.
33. McCall MN, Irizarry RA., Thawing frozen robust multi-array analysis (fRMA). BMC Bioinformatics 2011; 12: 369.
34. Robin X, Turck N, Hainard A, et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12: 77.
35. GP GraphPad QuickCalcs: Free statistical calculators. Available at: http://www.graphpad.com/quickcalcs/index.cfm. Accessed October 26, 2012.
36. PA. Power Atlas. Available at: http://www.poweratlas.org/. Accessed October 26, 2012.
37. Suthanthiran M, Schwartz JE, Ding R, et al. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med 2013; 369: 20-31.
38. Hricik DE, Nickerson P, Formica RN, et al. Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. Am J Transplant 2013; 13: 2634-2644.
39. Mengel M, Sis B, Halloran PF., SWOT analysis of Banff: Strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant 2007; 7: 2221-2226.